Brachytherapy with Iodine 125 (Gliasite™) in recurrent malignant gliomas – results of a prospective ongoing trial

J. Piek, G. Klautke, C. Schümichen & M. Schütze
Objective: This current study was designed to evaluate the therapeutic effect and eventual side-effects of an additional brachytherapy (Iodine 125, Gliasite®) in patients operated for recurrent malignant gliomas. Methods: Quality of life and outcome as well as therapeutic side-effects of an [for full text, please go to the a.m. URL]